Primecap Management CO Eli Lilly & CO Transaction History

Primecap Management CO

$122 Billion
Q2 2025

A detailed history of Primecap Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Primecap Management CO holds 12,154,908 shares of LLY stock, worth $10.3 Billion. This represents 7.74% of its overall portfolio holdings.

Number of Shares

12,154,908

Previous 14,779,770 17.76%

Holding current value

$10.3 Billion

Previous $12.2 Billion 22.38%

% of portfolio

7.74%

Previous 10.32%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$713.71 - $898.95 $1.87 Billion - $2.36 Billion	-2,624,862 Reduced 17.76%	12,154,908 $9.48 Billion
Q1 2025 May 09, 2025	SELL	$725.72 - $929.72 $1.43 Billion - $1.84 Billion	-1,976,884 Reduced 11.8%	14,779,770 $12.2 Billion
Q4 2024 Feb 10, 2025	SELL	$727.2 - $932.06 $679 Million - $870 Million	-933,854 Reduced 5.28%	16,756,654 $12.9 Billion
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $1.49 Billion - $1.85 Billion	-1,927,574 Reduced 9.83%	17,690,508 $15.7 Billion
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $1.19 Billion - $1.49 Billion	-1,636,108 Reduced 7.7%	19,618,082 $17.8 Billion
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $560 Million - $750 Million	-946,344 Reduced 4.26%	21,254,190 $16.5 Billion
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $453 Million - $534 Million	-863,002 Reduced 3.74%	22,200,534 $12.9 Billion
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $210 Million - $289 Million	-482,665 Reduced 2.05%	23,063,536 $12.4 Billion
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $639 Million - $854 Million	-1,821,349 Reduced 7.18%	23,546,201 $11 Billion
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $163 Million - $191 Million	-524,475 Reduced 2.03%	25,367,550 $8.71 Billion
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $683 Million - $796 Million	-2,125,130 Reduced 7.59%	25,892,025 $9.47 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $125 Million - $142 Million	-421,333 Reduced 1.48%	28,017,155 $9.06 Billion
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $121 Million - $142 Million	-434,743 Reduced 1.51%	28,438,488 $9.22 Billion
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $192 Million - $238 Million	-817,450 Reduced 2.75%	28,873,231 $8.27 Billion
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $677 Million - $840 Million	-3,010,305 Reduced 9.21%	29,690,681 $8.2 Billion
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $279 Million - $343 Million	-1,258,281 Reduced 3.71%	32,700,986 $7.56 Billion
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $256 Million - $331 Million	-1,418,968 Reduced 4.01%	33,959,267 $7.79 Billion
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $227 Million - $293 Million	-1,378,950 Reduced 3.75%	35,378,235 $6.61 Billion
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $159 Million - $210 Million	-1,218,139 Reduced 3.21%	36,757,185 $6.21 Billion
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $242 Million - $280 Million	-1,652,633 Reduced 4.17%	37,975,324 $5.62 Billion
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $315 Million - $379 Million	-2,307,345 Reduced 5.5%	39,627,957 $6.51 Billion
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $142 Million - $175 Million	-1,189,416 Reduced 2.76%	41,935,302 $5.82 Billion
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $31.3 Million - $38.8 Million	293,082 Added 0.68%	43,124,718 $5.67 Billion
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $35.4 Million - $38.5 Million	-331,484 Reduced 0.77%	42,831,636 $4.79 Billion
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $8.26 Million - $9.65 Million	-74,584 Reduced 0.17%	43,163,120 $4.78 Billion
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $820 Million - $965 Million	-7,365,752 Reduced 14.56%	43,237,704 $5.61 Billion
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $444 Million - $497 Million	-4,188,112 Reduced 7.64%	50,603,456 $5.86 Billion
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $26.7 Million - $33.4 Million	-310,946 Reduced 0.56%	54,791,568 $5.88 Billion
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $42.1 Million - $48.3 Million	555,731 Added 1.02%	55,102,514 $4.7 Billion
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $45 Million - $53.1 Million	-605,794 Reduced 1.1%	54,546,783 $4.22 Billion
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $43.4 Million - $46.6 Million	-529,945 Reduced 0.95%	55,152,577 $4.66 Billion
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $4.29 Billion - $4.76 Billion	55,682,522	55,682,522 $4.76 Billion

Others Institutions Holding LLY

# of Institutions

4,451

Shares Held

781M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $804B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Eli Lilly & CO Transaction History